<SEC-DOCUMENT>0001654954-16-004549-index.html : 20161202
<SEC-HEADER>0001654954-16-004549.hdr.sgml : 20161202
<ACCEPTANCE-DATETIME>20161202172206
ACCESSION NUMBER:		0001654954-16-004549
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20161201
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20161202
DATE AS OF CHANGE:		20161202

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CEL SCI CORP
		CENTRAL INDEX KEY:			0000725363
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				840916344
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-11889
		FILM NUMBER:		162032052

	BUSINESS ADDRESS:	
		STREET 1:		8229 BOONE BLVD .
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182
		BUSINESS PHONE:		7035069460

	MAIL ADDRESS:	
		STREET 1:		8229 BOONE BLVD.
		STREET 2:		SUITE 802
		CITY:			VIENNA
		STATE:			VA
		ZIP:			22182

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTERLEUKIN 2 INC
		DATE OF NAME CHANGE:	19880317
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cvm_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: cvm_8k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>cvm_ex11.htm
<DESCRIPTION>LETTER AGREEMENT
<TEXT>
Document 2 - file: cvm_ex11.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.I
<SEQUENCE>3
<FILENAME>cvm_ex4i.htm
<DESCRIPTION>FORM OF WARRANT SERIES CC
<TEXT>
Document 3 - file: cvm_ex4i.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.J
<SEQUENCE>4
<FILENAME>cvm_ex4j.htm
<DESCRIPTION>FORM OF WARRANT SERIES DD
<TEXT>
Document 4 - file: cvm_ex4j.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.K
<SEQUENCE>5
<FILENAME>cvm_ex4k.htm
<DESCRIPTION>FORM OF WARRANT SERIES EE
<TEXT>
Document 5 - file: cvm_ex4k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.L
<SEQUENCE>6
<FILENAME>cvm_ex4l.htm
<DESCRIPTION>PLACEMENT AGENT WARRANT SERIES FF
<TEXT>
Document 6 - file: cvm_ex4l.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5
<SEQUENCE>7
<FILENAME>cvm_ex5.htm
<DESCRIPTION>OPINION OF HART AND HART LLC
<TEXT>
Document 7 - file: cvm_ex5.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.PPP
<SEQUENCE>8
<FILENAME>cvm_ex10pp.htm
<DESCRIPTION>FORM OF SECURITIES PURCHASE AGREEMENT
<TEXT>
Document 8 - file: cvm_ex10pp.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>9
<FILENAME>cvm_ex23.htm
<DESCRIPTION>CONSENT OF HART AND HART LLC
<TEXT>
Document 9 - file: cvm_ex23.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>10
<FILENAME>cvm_ex991.htm
<DESCRIPTION>PRESS RELEASE DATED DECEMBER 1, 2016
<TEXT>
Document 10 - file: cvm_ex991.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>11
<FILENAME>cvm_ex992.htm
<DESCRIPTION>PRESS RELEASE DATED DECEMBER 2, 2016
<TEXT>
Document 11 - file: cvm_ex992.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>cvm_ex11000.jpg
<DESCRIPTION>IMAGE
<TEXT>
Document 12 - file: cvm_ex11000.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>cvm_ex992000.jpg
<DESCRIPTION>IMAGE
<TEXT>
Document 13 - file: cvm_ex992000.jpg

</DOCUMENT>
</SEC-DOCUMENT>